16 / 23
Fanconi anemie
1.
SKION-DCOG-richtlijn Fanconi Anemie, versie 2016 .2.
Fanconi Anemia Research Fund, Inc.
Fanconi anemia: guidelines for diagnosis and management. 4
th
edition, 2014.
3.
Alter B. Cancer in Fanconi anemia, 1927-2001. Cancer 2003;97:425-40.
4.
Ameziane N, May P, Haitjema A, van de Vrugt H, Van Rossum-Fikkert S, Ristic D, et al. A novel Fanconi anaemia subtype associated
with a dominant-negative mutation in RAD51. Nat Commun 2015;6:8829.
5.
Auerbach A. Fanconi Anemia and its diagnosis. Mutat Res 2009;668:4-10.
6.
Degrolard-Courcet E, Sokolowska J, Padeano M, Guiu S, Bronner M, Chery C, et al. Development of primary early-onset colorectal
cancers due to biallelic mutations of the FANCD1/BRCA2 gene. Eur J HumGenet 2014;22:979–87.
7.
Hendriks S.
Generieke zorgthema Huisartsgeneeskundige zorg. 2014.
8.
Kutler D, Auerbach A, Satagopan J, Glampietro P, Dev Batisch S, Huvos A, et al. High incidence of head and neck squamous cell
carcinoma in patients with Fanconi anemia. Arch Otolaryngol Head Neck Surg 2003;129:106-12.
9.
Sawyer S, Tian L, Kähkönen M, Schwartzentruber J, Kircher M, University of Washington Centre for Mendelian Genomics, et al.
Biallelic mutations in BRCA1 cause a new Fanconi anemia subtype. Cancer Discov 2015;5:135–42.
10. Scott R, Walker L, Olsen Ø, Levitt G, Kenney I, Maher E, et al. Surveillance for Wilms tumour in at-risk children: pragmatic
recommendations for best practice. Arch Dis Child 2006;91:995–9.
11. Smetsers S, Zwaan C, Sonnevelt M, Brakenhoff R, Smiers F, Best J, et al. Fanconi-anemie: uit de kinderschoenen. Ned Tijdschr
Hematol 2010;7:230-40.
12. Tischkowitz M, Hodgson S. Fanconi anaemia. J Med Genet 2003;40:1–10.
13. Tischkowitz M, Xia B. PALB2/FANCN - recombining cancer and Fanconi anemia. Cancer Res 2010;70:7353–9.
14. Vajda I.
Visiedocument Concentratie en organisatie van zorg bij zeldzame aandoeningen.2015.
15. Velazquez I, Alter B. Androgens and liver tumors: Fanconi’s anemia and non-Fanconi’s conditions. Am J Hematol 2004;77:257–67.
16. Virts E, Jankowska A, Mackay C , Glaas M, Wiek C, Kelich S, et al. AluY-mediated germline deletion, duplication and somatic stem
cell reversion in UBE2T defines a new subtype of Fanconi anemia. Human Molecular Genetics 2015:24;5093–108.
Literatuurlijst
14